CARCINOID-SYNDROME DUE TO A MALIGNANT SOMATOSTATINOMA

被引:2
作者
OZBAKIR, O
KELESTIMUR, F
OZTURK, F
SOZUER, E
UNAL, A
PATIROGLU, TE
GUVEN, K
机构
[1] ERCIYES UNIV,TIP FAK IC,SCH MED,DEPT INTERNAL MED,KAYSERI 38039,TURKEY
[2] ERCIYES UNIV,SCH MED,DEPT PATHOL,KAYSERI 38039,TURKEY
[3] ERCIYES UNIV,SCH MED,DEPT SURG,KAYSERI 38039,TURKEY
关键词
SOMATOSTATINOMA; CARCINOID SYNDROME; OCTREOTIDE;
D O I
10.1136/pgmj.71.841.695
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Somatostatinoma is one of the rarest tumours of the endocrine pancreas. Cardinal manifestations of a somatostatinoma include gallstones, mild diabetes mellitus, steatorrhoea, diarrhoea and dyspepsia. Like any other pancreatic islet cell carcinoma, a somatostatinoma may also produce several different hormones such as adrenocorticotropic hormone, calcitonin, vasoactive intestinal polypeptide, pancreatic polypeptide, gastrin, insulin, and glucagon. In many cases, the clinical picture is dominated by the effect of these other hormones. We present a patient with somatostatinoma in which an immunocytochemical study of the specimens from pancreas and liver showed a weak positive reaction for gastrin besides a strong positive reaction for somatostatin, Interestingly, this patient also showed the signs of carcinoid syndrome which was successfully treated with octreotide.
引用
收藏
页码:695 / 698
页数:4
相关论文
共 50 条
  • [31] Carcinoid Syndrome: A Review
    Gade, Ajay K.
    Olariu, Eva
    Douthi, Nathan T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [32] Pancreatic somatostatinoma with obscure inhibitory syndrome and mixed pathological pattern
    Zhang, Bo
    Xie, Qiu-ping
    Gao, Shun-liang
    Fu, Yan-biao
    Wu, Yu-lian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2010, 11 (01): : 22 - 26
  • [33] Cases in a series of carcinoid syndrome and carcinoid heart disease
    Matshela, Mamotabo R.
    CARDIOVASCULAR JOURNAL OF AFRICA, 2018, 29 (04) : E1 - E7
  • [34] Pancreatic somatostatinoma with obscure inhibitory syndrome and mixed pathological pattern
    Bo Zhang
    Qiu-ping Xie
    Shun-liang Gao
    Yan-biao Fu
    Yu-lian Wu
    Journal of Zhejiang University SCIENCE B, 2010, 11 : 22 - 26
  • [35] An update of lanreotide acetate for treatment of adults with carcinoid syndrome
    Guadelupe, E.
    Deshpande, H. A.
    Stein, S. M.
    DRUGS OF TODAY, 2018, 54 (08) : 457 - 465
  • [36] Perioperative Management of Patients with Carcinoid Syndrome/Neuroendocrine Neoplasm
    Binas, D.
    Schubert, A-K
    Wiese, D.
    Wulf, H.
    Wiesmann, T.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2020, 61 : 16 - 24
  • [37] Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review
    Wolin, Edward M.
    Benson, Al Bowen, III
    ONCOLOGY, 2019, 96 (06) : 273 - 289
  • [38] Primary carcinoid tumor of the bilateral testis associated with carcinoid syndrome
    Son, HY
    Ra, SW
    Jeong, JO
    Koh, EH
    Lee, HI
    Koh, JM
    Kim, WB
    Park, JY
    Shong, YK
    Lee, KU
    Kim, GS
    Kim, MS
    INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (11) : 1041 - 1043
  • [40] Management of ovarian carcinoid syndrome
    Pappa, Irene
    Peros, George
    Lappas, Chris
    Vassiliu, Pantelis
    Arkadopoulos, Nikolaos
    Smyrniotis, Vassilios
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2011, 115 (02) : 205 - 207